Related Experiment Videos
Mechanisms of iPS cell generation and beyond
1MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom.
The Keio Journal of Medicine
|March 31, 2017
Summary
Overexpression of master transcription factors (TFs) can reprogram cells. Researchers identified novel genes that either block or facilitate cell conversion, advancing regenerative medicine.
Area of Science:
- Cellular reprogramming and regenerative medicine
- Epigenetic landscape and cellular identity
- Gene regulation and cell fate determination
Background:
- Induced pluripotent stem cells (iPSCs) and master transcription factor (TF)-mediated transdifferentiation have transformed cell engineering.
- The molecular mechanisms underlying diverse cellular identity changes during reprogramming are not fully understood.
- Constitutive active Smad3 overexpression enhances iPSC generation and other TF-mediated cell conversions, suggesting common underlying mechanisms.
Purpose of the Study:
- To investigate the common molecular mechanisms of master TF-mediated cell conversions.
- To identify novel genes involved in or hindering the reprogramming process.
- To provide a valuable resource for improving cell conversion efficiency in regenerative medicine.
Main Methods:
- CRISPR/Cas9-mediated genome-wide knockout screening was employed during reprogramming.
- A lentiviral gRNA library containing 90,000 gRNAs was utilized for the screening.
- Reprogramming efficiency and cellular identity changes were analyzed.
Main Results:
- Approximately 15 novel reprogramming roadblock genes were identified.
- Around 20 candidate genes essential for reprogramming but not ES cell self-renewal were discovered.
- The study demonstrated common mechanisms underlying different master TF-mediated cell conversions.
Conclusions:
- Master TF-mediated cell conversions share common underlying mechanisms.
- The identified genes provide insights into cellular identity alteration during reprogramming.
- This research offers a valuable resource for advancing regenerative medicine through enhanced cell conversion strategies.